---
title: ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings
  from low dose CT screening for lung cancer
date: '2023-10-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37804174/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231007180812&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This European collaborative group has produced an incidental
  findings statement that can be followed during lung cancer screening. It will ensure
  that an evidence-based approach is used for reporting and managing incidental findings,
  which will mean that harms are minimised and any programme is as cost-effective
  as ...'
disable_comments: true
---
CONCLUSIONS: This European collaborative group has produced an incidental findings statement that can be followed during lung cancer screening. It will ensure that an evidence-based approach is used for reporting and managing incidental findings, which will mean that harms are minimised and any programme is as cost-effective as ...